Encouraged by the in vitro results obtained with T cells expressing anti-EpCAM RNA CAR, we next tested their in vivo tumor-killing efficiency in the intraperitoneal xenograft mouse model of human ovarian cancer described above. Here, EPCAM is linked to ovarian carcinoma.